Rationale and design of the CANARI study: a case ‐control study investigating the association between prostate cancer and 5 alpha‐reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France

This article is protected by copyright. All rights reserved.

Source: Fundamental and Clinical Pharmacology - August 1, 2017 Category: Drugs & Pharmacology Authors: Lucie ‐Marie Scailteux, Frédéric Balusson, Sébastien Vincendeau, Nathalie Rioux‐Leclercq, Emmanuel Nowak Tags: Original Article Source Type: research